Test Procedure for (j) Calculate and Submit Clinical Quality Measures

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Test Procedure for 170.304 (j) Calculate and Submit Clinical Quality Measures"

Transcription

1 Test Procedure for (j) Calculate and Submit Clinical Quality Measures This document describes the draft test procedure for evaluating conformance of complete EHRs or EHR modules 1 to the certification criteria defined in 45 CFR Part 170 Subpart C of the Final Rule for Health Information Technology: Initial Set of standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology as published in the Federal Register on July 28, The document 2 is organized by test procedure and derived test requirements with traceability to the normative certification criteria as described in the Overview document located at The test procedures may be updated to reflect on-going feedback received during the certification activities. The HHS/Office of the National Coordinator for Health Information Technology (ONC) has defined the standards, implementation guides and certification criteria used in this test procedure. Applicability and interpretation of the standards, implementation guides and certification criteria to EHR technology is determined by ONC. Test procedures to evaluate conformance of EHR technology to ONC s requirements are defined by NIST. Testing of EHR technology is carried out by ONC-Authorized Testing and Certification Bodies (ATCBs), not NIST, as set forth in the final rule establishing the Temporary Certification Program (Establishment of the Temporary Certification Program for Health Information Technology, 45 CFR Part 170; June 24, 2010.) Questions about the applicability of the standards, implementation guides or criteria should be directed to ONC at Questions about the test procedures should be directed to NIST at Note that NIST will automatically forward to ONC any questions regarding the applicability of the standards, implementation guides or criteria. Questions about functions and activities of the ATCBs should be directed to ONC at CERTIFICATION CRITERIA This Certification Criterion is from the Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology Final Rule issued by the Department of Health and Human Services (HHS) on July 28, (j) Calculate and submit clinical quality measures. (1) Calculate. (i) Electronically calculate all of the core clinical measures specified by CMS for eligible professionals. 1 Department of Health and Human Services, 45 CFR Part 170 Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, Final Rule, July 28, Disclaimer: Certain commercial products are identified in this document. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology. 1

2 (ii) Electronically calculate, at a minimum, three clinical quality measures specified by CMS for eligible professionals, in addition to those clinical quality measures specified in paragraph (1)(i). (2) Submission. Enable a user to electronically submit calculated clinical quality measures in accordance with the standard and implementation specifications specified in (f). Per Section III.D of the preamble of the Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, Final Rule where the calculate and submit clinical quality measures certification criterion is discussed: In light of the final approach CMS has taken with respect to clinical quality measures for meaningful use Stage 1, we have revised this certification to better align it with the Medicare and Medicaid EHR Incentive Programs final rule requirements. We also agree with those commenters that requested we explicitly focus the report of quality measures certification criterion, and the certification criteria in general, on Federal requirements and have removed the reference to or States in this certification criterion. To better align this certification criterion with the final approach to clinical quality measures in the Medicare and Medicaid EHR Incentive Programs final rule, we have determined that it is no longer sufficient to specify one general certification criterion for both Complete EHRs and EHR Modules designed for either an ambulatory or inpatient setting. Complete EHRs and EHR Modules designed for an ambulatory setting will be required to be tested and certified as being compliant with all 6 of the core (3 core and 3 alternate core) clinical quality measures specified by CMS for eligible professionals (Section II(A)(3) of the Medicare and Medicaid EHR Incentive Programs final rule). Complete EHRs and EHR Modules designed for an ambulatory setting will also be required to be tested and certified as being compliant with, at a minimum, 3 of the additional clinical quality measures CMS has identified for eligible professionals (Section II(A)(3)of the Medicare and Medicaid EHR Incentive Programs final rule). INFORMATIVE TEST DESCRIPTION This section provides an informative description of how the test procedure is organized and conducted. It is not intended to provide normative statements of the certification requirements. This test evaluates the capability for a Complete EHR or EHR Moduleto electronically calculate all of the core clinical measures specified by CMS for eligible professionals; electronically calculate, at a minimum, three clinical quality measures specified by CMS for eligible professionals, excluding those core clinical quality measures specified previously; and electronically submit calculated clinical quality measures in accordance with the standard and implementation specifications specified in (f). This test procedure evaluates conformance to the Physician Quality Reporting Initiative (PQRI) standard and implementation specifications identified in the FR; however, the test procedure does not fully evaluate the correctness of the implemented algorithms or calculation of the quality measures based on Vendor test data. An automated test tool to determine the correct calculation of measures is currently under development through an HHS/ONC effort. 2

3 The Vendor provides the test data for this test procedure. This test procedure is organized into two sections: Calculate clinical quality measures evaluates the capability to electronically calculate 1. all six of the core clinical measures specified by CMS for eligible professionals and 2. at a minimum, three clinical quality measures specified by CMS for eligible professionals, excluding the six core clinical quality measures o The Tester examines the core clinical quality measures specified by CMS and implemented in the EHR o The Tester validates that these core quality measures are electronically calculated by the EHR o The Tester examines the three or more clinical quality measures (excluding the six core clinical quality measures) specified by CMS for eligible professionals and implemented in the EHR o The Tester validates that these three or more clinical quality measures are electronically calculated by the EHR o The Tester will evaluate, to the extent possible given the Vendor-supplied data used in this Test Procedure, the calculations of the measures as described by the Vendor Submit calculated clinical quality measures evaluates the capability to electronically submit calculated quality measures in accordance with the standard and implementation specifications o The Tester electronically submits the clinical quality measures calculated in the Calculate Clinical Quality Measures test o The Tester validates that the calculated clinical quality measures are submitted in accordance with the PQRI standard and implementation specifications o The Tester will evaluate, to the extent possible given the Vendor-supplied data used in this Test Procedure, the calculations of the measures as described by the Vendor REFERENCED STANDARDS Content exchange standards and implementation specifications for exchanging electronic health information. Regulatory Referenced Standard (f) Quality reporting. Standard. The CMS Physician Quality Reporting Initiative (PQRI) 2009 Registry XML Specification (incorporated by reference in ). Implementation specifications. Physician Quality Reporting Initiative Measure Specifications Manual for Claims and Registry (incorporated by reference in ). 3

4 NORMATIVE TEST PROCEDURES Derived Test Requirements DTR j 1: Electronically calculate clinical quality measures DTR j 2: Electronically submit calculated clinical quality measures DTR j 1: Electronically calculate clinical quality measures Required Vendor Information VE j 1.01: VE j 1.02: VE j 1.03: VE j 1.04: Vendor shall provide the test data necessary to accomplish the test procedure Vendor shall describe the calculations for the specified CMS core clinical quality measures that are implemented in the EHR to be used for this test Vendor shall identify and describe the calculations for the three or more of the specified CMS clinical quality measures (excluding the core clinical quality measures) that are implemented in the EHR to be used for this test Vendor shall identify the EHR function(s) that are available to: 1) electronically calculate the CMS clinical quality measures 2) electronically submit calculated clinical quality measures Required Test Procedure: TE j 1.01: TE j 1.02: TE j 1.03: TE j 1.04: Using the EHR function(s) identified by the Vendor, the Tester shall electronically calculate the specified CMS core clinical quality measures Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the core clinical quality measures are electronically calculated Using the EHR function(s) identified by the Vendor and three or more of the specified CMS clinical quality measures identified by the Vendor in VE j 1.03, the Tester shall electronically calculate these CMS clinical quality measures Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the three or more of the specified CMS clinical quality measures are electronically calculated Inspection Test Guide IN j 1.01: Using the specified CMS core clinical quality measures listed in the table below, Tester shall verify that these clinical quality measures are calculated as described by the Vendor in VE j 1.02 Specified CMS Core and Alternate Core Clinical Quality Measures for Eligible Professionals Per Department of Health and Human Services, Centers for Medicare & Medicaid Services, 42 CFR Parts 412, 413, 422, and 495, CMS-0033-F, RIN 0938-AP78, Medicare and Medicaid Programs; Electronic Health Record Incentive Program, Final Rule, July 28,

5 NQF 0421 PQRI 128 NQF 0013 Title: Adult Weight Screening and Follow-Up Description: Percentage of patients aged 18 years and older with a calculated BMI in the past six months or during the current visit documented in the medical record AND if the most recent BMI is outside parameters, a follow-up plan is documented. Title: Hypertension: Blood Pressure Measurement Description: Percentage of patient visits for patients aged 18 years and older with a diagnosis of hypertension who have been seen for at least 2 office visits, with blood pressure (BP) recorded. NQF 0028 Title: Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment, b. Tobacco Cessation Intervention Description: Percentage of patients aged 18 years and older who have been seen for at least 2 office visits who were queried about tobacco use one or more times within 24 months b. Percentage of patients aged 18 years and older identified as tobacco users within the past 24 months and have been seen for at least 2 office visits, who received cessation intervention. NQF 0041 PQRI 110 NQF 0024 NQF 0038 Title: Preventive Care and Screening: Influenza Immunization for Patients 50 Years Old Description: Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February). Title: Weight Assessment and Counseling for Children and Adolescents Description: Percentage of patients 2-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or OB/GYN and who had evidence of BMI percentile documentation, counseling for nutrition and counseling for physical activity during the measurement year. Title: Childhood Immunization Status Description: Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio(ipv), one measles,,mumps and rubella (MMR); two H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal conjugate (PCV); two hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine and nine separate combination rates. Core/Alternate Core Clinical Quality Measure Core Core Core Alternate Core Alternate Core Alternate Core The Tester will evaluate, to the extent possible given the Vendor-supplied test data used in this test procedure, the calculations of the measures as described by the Vendor. IN j 1.02: Using three or more of the specified CMS clinical quality measures listed in the table below and identified by the Vendor, Tester shall verify that these clinical 5

6 quality measures are calculated as described by the Vendor in VE j 1.03 Specified CMS Clinical Quality Measures for Eligible Professionals (excluding Core and Alternate Core Clinical Quality Measures) Per Department of Health and Human Services, Centers for Medicare & Medicaid Services, 42 CFR Parts 412, 413, 422, and 495, CMS-0033-F, RIN 0938-AP78, Medicare and Medicaid Programs; Electronic Health Record Incentive Program, Final Rule, July 28, NQF 0059 PQRI 1 NQF 0064 PQRI 2 NQF 0061 PQRI 3 NQF 0081 PQRI 5 NQF 0070 PQRI 7 NQF 0043 PQRI 111 NQF 0031 PQRI 112 NQF 0034 PQRI 113 NQF 0067 PQRI 6 NQF 0083 PQRI 8 Title: Diabetes: Hemoglobin A1c Poor Control Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had hemoglobin A1c > 9.0%. Title: Diabetes: Low Density Lipoprotein (LDL) Management and Control Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had LDL-C < 100 mg/dl). Title: Diabetes: Blood Pressure Management Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had blood pressure <140/90 mmhg. Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy. Title: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) diagnosis of CAD and prior MI who were prescribed beta-blocker therapy. Title: Pneumonia Vaccination Status for Older Adults Description: Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine. Title: Breast Cancer Screening Description: Percentage of women years of age who had a mammogram to screen for breast cancer. Title: Colorectal Cancer Screening Description: Percentage of adults years of age who had appropriate screening for colorectal cancer. Title: Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD diagnosis of CAD who were prescribed oral antiplatelet therapy. Title: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) diagnosis of heart failure who also have LVSD (LVEF < 40%) and who were prescribed beta-blocker therapy. 6

7 NQF 0105 PQRI 9 NQF 0086 PQRI 12 NQF 0088 PQRI 18 NQF 0089 PQRI 19 NQF 0047 PQRI 53 NQF 0001 PQRI 64 NQF 0002 PQRI 66 NQF 0387 PQRI 71 Title: Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment Description: The percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication treatment. Title: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation diagnosis of POAG who have been seen for at least two office visits who have an optic nerve head evaluation during one or more office visits within 12 months. Title: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months. Title: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months. Title: Asthma Pharmacologic Therapy Description: Percentage of patients aged 5 through 40 years with a diagnosis of mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment. Title: Asthma Assessment Description: Percentage of patients aged 5 through 40 years with a diagnosis of asthma and who have been seen for at least 2 office visits, who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms. Title: Appropriate Testing for Children with Pharyngitis Description: Percentage of children 2-18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode. Title: Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer Description: Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period. 7

8 NQF 0385 PQRI 72 NQF 0389 PQRI 102 NQF 0027 PQRI 115 NQF 0055 PQRI 117 NQF 0062 PQRI 119 NQF 0056 PQRI 163 NQF 0074 PQRI 197 NQF 0084 PQRI 200 NQF 0073 PQRI 201 Title: Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients Description: Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period. Title: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients Description: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer. Title: Smoking and Tobacco Use Cessation, Medical assistance: a. Advising Smokers and Tobacco Users to Quit, b. Discussing Smoking and Tobacco Use Cessation Medications, c. Discussing Smoking and Tobacco Use Cessation Strategies Description: Percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods or strategies. Title: Diabetes: Eye Exam Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had a retinal or dilated eye exam or a negative retinal exam (no evidence of retinopathy) by an eye care professional. Title: Diabetes: Urine Screening Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had a nephropathy screening test or evidence of nephropathy. Title: Diabetes: Foot Exam Description: The percentage of patients aged years with diabetes (type 1 or type 2) who had a foot exam (visual inspection, sensory exam with monofilament, or pulse exam). Title: Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL- Cholesterol diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines). Title: Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation Description: Percentage of all patients aged 18 years and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy. Title: Ischemic Vascular Disease (IVD): Blood Pressure Management Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1- November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose recent blood pressure is in control (<140/90 mmhg). 8

9 NQF 0068 PQRI 204 NQF 0004 NQF 0012 NQF 0014 NQF 0018 NQF 0032 NQF 0033 NQF 0036 NQF 0052 NQF 0075 Title: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1-November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year. Title: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement Description: The percentage of adolescent and adult patients with a new episode of alcohol and other drug (AOD) dependence who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter or partial hospitalization within 14 days of the diagnosis and who initiated treatment and who had two or more additional services with an AOD diagnosis within 30 days of the initiation visit. Title: Prenatal Care: Screening for Human Immunodeficiency Virus (HIV) Description: Percentage of patients, regardless of age, who gave birth during a 12-month period who were screened for HIV infection during the first or second prenatal care visit. Title: Prenatal Care: Anti-D Immune Globulin Description: Percentage of D (Rh) negative, unsensitized patients, regardless of age, who gave birth during a 12-month period who received anti-d immune globulin at weeks gestation. Title: Controlling High Blood Pressure Description: The percentage of patients years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year Title: Cervical Cancer Screening Description: Percentage of women years of age, who received one or more Pap tests to screen for cervical cancer Title: Chlamydia Screening for Women Description: Percentage of women years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year. Title: Use of Appropriate Medications for Asthma Description: Percentage of patients 5-50 years of age who were identified as having persistent asthma and were appropriately prescribed medication during the measurement year. Report three age stratifications (5-11 years, years, and total). Title: Low Back Pain: Use of Imaging Studies Description: Percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain x-ray, MRI, CT scan) within 28 days of diagnosis. Title: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal angioplasty (PTCA) from January 1-November1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had a complete lipid profile performed during the measurement year and whose LDL-C<100 mg/dl. 9

10 NQF 0575 Title: Diabetes: Hemoglobin A1c Control (<8.0%) Description: The percentage of patients years of age with diabetes (type 1 or type 2) who had hemoglobin A1c <8.0%. The Tester will evaluate, to the extent possible given the Vendor-supplied test data used in this test procedure, the calculations of the measures as described by the Vendor. DTR j 2: Electronically submit calculated clinical quality measures Required Vendor Information As defined in DTR j 1, no additional information is required Required Test Procedure: TE j 2.01: TE j 2.02: Using the EHR function(s) identified by the Vendor, the Tester shall submit one or more of the specified CMS clinical quality measures from the DTR j 1: Electronically calculate clinical quality measures test Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the clinical quality measures are submitted in conformance with the PQRI standard and implementation specifications referenced in the FR Inspection Test Guide IN j 2.01: Tester shall visually inspect the submitted PQRI XML document for one or more of the specified CMS clinical quality measures in the tables below and verify that, at a minimum, the following information is present and the data tags are appropriate: Submission-period-from-date Submission-period-to-date Submission method Measure group Provider National Provider Identifier PQRI measure PQRI measure number Eligible instances (reporting denominator) Meets performance (performance numerator) Performance exclusion instances Performance not met instances Reporting rate Performance rate 10

11 Specified CMS Core and Alternate Core Clinical Quality Measures for Eligible Professionals Per Department of Health and Human Services, Centers for Medicare & Medicaid Services, 42 CFR Parts 412, 413, 422, and 495, CMS-0033-F, RIN 0938-AP78, Medicare and Medicaid Programs; Electronic Health Record Incentive Program, Final Rule, July 28, NQF 0421 PQRI 128 NQF 0013 Title: Adult Weight Screening and Follow-Up Description: Percentage of patients aged 18 years and older with a calculated BMI in the past six months or during the current visit documented in the medical record AND if the most recent BMI is outside parameters, a follow-up plan is documented. Title: Hypertension: Blood Pressure Measurement Description: Percentage of patient visits for patients aged 18 years and older with a diagnosis of hypertension who have been seen for at least 2 office visits, with blood pressure (BP) recorded. NQF 0028 Title: Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment, b. Tobacco Cessation Intervention Description: Percentage of patients aged 18 years and older who have been seen for at least 2 office visits who were queried about tobacco use one or more times within 24 months b. Percentage of patients aged 18 years and older identified as tobacco users within the past 24 months and have been seen for at least 2 office visits, who received cessation intervention. NQF 0041 PQRI 110 NQF 0024 NQF 0038 Title: Preventive Care and Screening: Influenza Immunization for Patients 50 Years Old Description: Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February). Title: Weight Assessment and Counseling for Children and Adolescents Description: Percentage of patients 2-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or OB/GYN and who had evidence of BMI percentile documentation, counseling for nutrition and counseling for physical activity during the measurement year. Title: Childhood Immunization Status Description: Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio(ipv), one measles,,mumps and rubella (MMR); two H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal conjugate (PCV); two hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine and nine separate combination rates. Core/Alternate Core Clinical Quality Measure Core Core Core Alternate Core Alternate Core Alternate Core 11

12 Specified CMS Clinical Quality Measures for Eligible Professionals (excluding Core and Alternate Core Clinical Quality Measures) Per Department of Health and Human Services, Centers for Medicare & Medicaid Services, 42 CFR Parts 412, 413, 422, and 495, CMS-0033-F, RIN 0938-AP78, Medicare and Medicaid Programs; Electronic Health Record Incentive Program, Final Rule, July 28, NQF 0059 PQRI 1 NQF 0064 PQRI 2 NQF 0061 PQRI 3 NQF 0081 PQRI 5 NQF 0070 PQRI 7 NQF 0043 PQRI 111 NQF 0031 PQRI 112 NQF 0034 PQRI 113 NQF 0067 PQRI 6 NQF 0083 PQRI 8 NQF 0105 PQRI 9 Title: Diabetes: Hemoglobin A1c Poor Control Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had hemoglobin A1c > 9.0%. Title: Diabetes: Low Density Lipoprotein (LDL) Management and Control Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had LDL-C < 100 mg/dl). Title: Diabetes: Blood Pressure Management Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had blood pressure <140/90 mmhg. Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy. Title: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) diagnosis of CAD and prior MI who were prescribed beta-blocker therapy. Title: Pneumonia Vaccination Status for Older Adults Description: Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine. Title: Breast Cancer Screening Description: Percentage of women years of age who had a mammogram to screen for breast cancer. Title: Colorectal Cancer Screening Description: Percentage of adults years of age who had appropriate screening for colorectal cancer. Title: Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD diagnosis of CAD who were prescribed oral antiplatelet therapy. Title: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) diagnosis of heart failure who also have LVSD (LVEF < 40%) and who were prescribed beta-blocker therapy. Title: Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment Description: The percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication treatment. 12

13 NQF 0086 PQRI 12 NQF 0088 PQRI 18 NQF 0089 PQRI 19 NQF 0047 PQRI 53 NQF 0001 PQRI 64 NQF 0002 PQRI 66 NQF 0387 PQRI 71 NQF 0385 PQRI 72 Title: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation diagnosis of POAG who have been seen for at least two office visits who have an optic nerve head evaluation during one or more office visits within 12 months. Title: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months. Title: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months. Title: Asthma Pharmacologic Therapy Description: Percentage of patients aged 5 through 40 years with a diagnosis of mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment. Title: Asthma Assessment Description: Percentage of patients aged 5 through 40 years with a diagnosis of asthma and who have been seen for at least 2 office visits, who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms. Title: Appropriate Testing for Children with Pharyngitis Description: Percentage of children 2-18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode. Title: Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer Description: Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period. Title: Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients Description: Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period. 13

14 NQF 0389 PQRI 102 NQF 0027 PQRI 115 NQF 0055 PQRI 117 NQF 0062 PQRI 119 NQF 0056 PQRI 163 NQF 0074 PQRI 197 NQF 0084 PQRI 200 NQF 0073 PQRI 201 Title: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients Description: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer. Title: Smoking and Tobacco Use Cessation, Medical assistance: a. Advising Smokers and Tobacco Users to Quit, b. Discussing Smoking and Tobacco Use Cessation Medications, c. Discussing Smoking and Tobacco Use Cessation Strategies Description: Percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods or strategies. Title: Diabetes: Eye Exam Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had a retinal or dilated eye exam or a negative retinal exam (no evidence of retinopathy) by an eye care professional. Title: Diabetes: Urine Screening Description: Percentage of patients years of age with diabetes (type 1 or type 2) who had a nephropathy screening test or evidence of nephropathy. Title: Diabetes: Foot Exam Description: The percentage of patients aged years with diabetes (type 1 or type 2) who had a foot exam (visual inspection, sensory exam with monofilament, or pulse exam). Title: Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL- Cholesterol diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines). Title: Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation Description: Percentage of all patients aged 18 years and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy. Title: Ischemic Vascular Disease (IVD): Blood Pressure Management Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1- November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose recent blood pressure is in control (<140/90 mmhg). 14

15 NQF 0068 PQRI 204 NQF 0004 NQF 0012 NQF 0014 NQF 0018 NQF 0032 NQF 0033 NQF 0036 NQF 0052 NQF 0075 Title: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1-November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year. Title: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement Description: The percentage of adolescent and adult patients with a new episode of alcohol and other drug (AOD) dependence who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter or partial hospitalization within 14 days of the diagnosis and who initiated treatment and who had two or more additional services with an AOD diagnosis within 30 days of the initiation visit. Title: Prenatal Care: Screening for Human Immunodeficiency Virus (HIV) Description: Percentage of patients, regardless of age, who gave birth during a 12-month period who were screened for HIV infection during the first or second prenatal care visit. Title: Prenatal Care: Anti-D Immune Globulin Description: Percentage of D (Rh) negative, unsensitized patients, regardless of age, who gave birth during a 12-month period who received anti-d immune globulin at weeks gestation. Title: Controlling High Blood Pressure Description: The percentage of patients years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year Title: Cervical Cancer Screening Description: Percentage of women years of age, who received one or more Pap tests to screen for cervical cancer Title: Chlamydia Screening for Women Description: Percentage of women years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year. Title: Use of Appropriate Medications for Asthma Description: Percentage of patients 5-50 years of age who were identified as having persistent asthma and were appropriately prescribed medication during the measurement year. Report three age stratifications (5-11 years, years, and total). Title: Low Back Pain: Use of Imaging Studies Description: Percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain x-ray, MRI, CT scan) within 28 days of diagnosis. Title: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal angioplasty (PTCA) from January 1-November1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had a complete lipid profile performed during the measurement year and whose LDL-C<100 mg/dl. 15

16 NQF 0575 Title: Diabetes: Hemoglobin A1c Control (<8.0%) Description: The percentage of patients years of age with diabetes (type 1 or type 2) who had hemoglobin A1c <8.0%. TEST DATA This Test Procedure requires the vendor to supply the test data. The Tester shall address the following: Vendor-supplied test data shall ensure that the functional and interoperable requirements identified in the criterion can be adequately evaluated for conformance Vendor-supplied test data shall strictly focus on meeting the basic capabilities required of an EHR relative to the certification criterion rather than exercising the full breadth/depth of capability that an installed EHR might be expected to support Tester shall record as part of the test documentation the specific Vendor-supplied test data that was utilized for testing CONFORMANCE TEST TOOLS An automated test tool to determine the correct calculation of measures is currently under development through an HHS/ONC effort. 16

17 Document History Version Number Description Date Published 0.2 Original draft version February 26, Updated to reflect Final Rule July 21, Updated to remove Pending in header August 13,

Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use

Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use Clinical Quality Measures Clinical quality measures have been defined

More information

AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist

AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist On July 13, 2010, the US Centers for Medicare and Medicaid Services (CMS) released a Final Rule establishing the criteria with which

More information

Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs)

Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs) Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs) What is Meaningful Use? American Recovery and Reinvestment Act of 2009/Health Information Technology for Economic and Clinical

More information

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

More information

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

More information

Many of the changes that have been made to this final rule were directly responsive to CMA s comments.

Many of the changes that have been made to this final rule were directly responsive to CMA s comments. On July 13, 2010, the Centers for Medicare & Medicaid Services (CMS) released the final rule defining meaningful use of an electronic health record (EHR) system. The original version of this rule was released

More information

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Stage 1 Meaningful Use Criteria Physicians must meet all 15 Core Set objectives and measures and five of the 10 Menu Set objectives and measures. They also must report clinical quality measures (see separate

More information

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

Radiology Business Management Association Technology Task Force. Sample Request for Proposal Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic

More information

2012 Physician Quality Reporting System:

2012 Physician Quality Reporting System: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services R Official CMS Information for Medicare Fee-For-Service Providers 2012 Physician Quality : Medicare Electronic Health Record

More information

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012 Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives

More information

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs).

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs). ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs). The information contained in this document is also available

More information

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/ Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary 2010 What are the Requirements of Stage 1 Meaningful Use? Basic Overview of Stage 1 Meaningful Use: Reporting period

More information

Understanding the CMS. "Meaningful Use" Requirements. CME Course Announcements. Why CCME Promotes EHR/ HIE?

Understanding the CMS. Meaningful Use Requirements. CME Course Announcements. Why CCME Promotes EHR/ HIE? Understanding the CMS Final Rule "Meaningful Use" Requirements CME Course Announcements The Carolinas Center for Medical Excellence is accredited by the Accreditation Council for Continuing Medical Education

More information

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS The table below entitled Clinical Quality s for 2014 CMS EHR Incentive Programs for Eligible Professionals

More information

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary

More information

Stage 2 June 13, 2014

Stage 2 June 13, 2014 Stage 2 June 13, 2014 1 General Overview of Idaho Medicaid s EHR Incentive Program Stage 2 Meaningful Use (MU) Overview 2014 Reporting Helpful Resources 2 3 Medicaid can pay certain providers an incentive

More information

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS The table below entitled Clinical s for 2014 CMS EHR Incentive Programs for Eligible Professionals contains

More information

Medicare & Medicaid EHR Incentive Programs. Specifics of the Program for Eligible Professionals

Medicare & Medicaid EHR Incentive Programs. Specifics of the Program for Eligible Professionals Medicare & Medicaid EHR Incentive Programs Specifics of the Program for Eligible Professionals Today s Session This training will cover the following topics: EHR Incentive Programs a Background Who Is

More information

An Introduction to the Medicare EHR Incentive Program for Eligible Professionals

An Introduction to the Medicare EHR Incentive Program for Eligible Professionals EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) An Introduction to the Medicare EHR Incentive Program for Eligible Professionals cms.gov/ehrincentiveprograms

More information

2013 ACO Quality Measures

2013 ACO Quality Measures ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating

More information

Orchard Software Webinar August 19, 2010. Slide 1

Orchard Software Webinar August 19, 2010. Slide 1 Slide 1 An Update on ARRA and Its Impact on Laboratories Presented By: Curt Johnson VP of Sales & Marketing cjohnson@orchardsoft.com www.orchardsoft.com (800) 856-1948 Orchard Software Webinar August 19,

More information

We're Ready for MU2...Are You?

We're Ready for MU2...Are You? Meaningful Use Are you considering purchasing an Electronic Health Record (EHR) or moving from your current vendor? Is your goal to attain Meaningful Use status in order to receive EHR incentive dollars?

More information

2012 American College of Radiology Posted: 9/4/12; Updated 9/20/12 1

2012 American College of Radiology Posted: 9/4/12; Updated 9/20/12 1 American College of Radiology Summary: CMS Stage 2 EHR Incentive Program & ONC 2014 Edition EHR Certification Criteria/Standards September 4, 2012 Final Rules Originally Posted: September 4, 2012 / Updated:

More information

An Introduction to the Medicare EHR Incentive Program for Eligible Professionals

An Introduction to the Medicare EHR Incentive Program for Eligible Professionals EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) An Introduction to the Medicare EHR Incentive Program for Eligible Professionals cms.gov/ehrincentiveprograms

More information

Primary Care in the U.S. Measuring and Improving Primary Care in the United States ISQua Indicators Summit 2012. CMS Measures. Primary Care Measures

Primary Care in the U.S. Measuring and Improving Primary Care in the United States ISQua Indicators Summit 2012. CMS Measures. Primary Care Measures Primary Care in the U.S. Measuring and Improving Primary Care in the United States ISQua Indicators Summit 2012 Cliff Fullerton, MD, MS VP Chronic Disease Baylor Health Care System Number of PCPs in the

More information

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE

More information

MEASURING CARE QUALITY

MEASURING CARE QUALITY MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance

More information

Teasing Some Meaning Out of Meaningful Use

Teasing Some Meaning Out of Meaningful Use Teasing Some Meaning Out of Meaningful Use An Overview Colorado Bar Association, Health Law Section December 15, 2010 Steve Nash, Partner SNash@PattonBoggs.com Melodi (Mel) Mosley Gates MGates@PattonBoggs.com

More information

Medicare & Medicaid EHR Incentive Program Specifics of the Program for Eligible Professionals. August 10, 2010

Medicare & Medicaid EHR Incentive Program Specifics of the Program for Eligible Professionals. August 10, 2010 Medicare & Medicaid EHR Incentive Program Specifics of the Program for Eligible Professionals August 10, 2010 Today s Session This training will cover the following topics: EHR Incentive Programs a Background

More information

AETNA BETTER HEALTH OF MISSOURI

AETNA BETTER HEALTH OF MISSOURI Aetna Better Health of Missouri 10 South Broadway, Suite 1200 St. Louis, MO 63102 800-566-6444 AETNA BETTER HEALTH OF MISSOURI HEDIS Quick Reference Billing Guide 2014 Diagnosis and/or procedure codes

More information

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Overview. http://www.cms.gov/ehrincentiveprograms/

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Overview. http://www.cms.gov/ehrincentiveprograms/ Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Overview 2010 What is Meaningful Use? Meaningful Use is using certified EHR technology to Improve quality, safety, efficiency,

More information

Care Gap Care Reminder Description Reference 900-2035-1210. Cardiovascular Persistence of Beta- Blocker Treatment After a Heart Attack (PBH)

Care Gap Care Reminder Description Reference 900-2035-1210. Cardiovascular Persistence of Beta- Blocker Treatment After a Heart Attack (PBH) Below is a list of the current Care Reminders shown in the Patient Care Summary Clinical Messaging section of the Availity web portal. These Florida Blue clinical alerts are based on claim data and are

More information

Clinical Quality Measures. for 2014

Clinical Quality Measures. for 2014 Clinical Quality Measures for 2014 Mission of OFMQHIT To advance the implementation and use of vital health information technology to improve healthcare quality, efficiency and safety by assisting physician

More information

12/15/2010. EMR Incentive Program for Eligible Professionals

12/15/2010. EMR Incentive Program for Eligible Professionals 12/15/2010 EMR Incentive Program for Eligible Professionals Topics for Today Meaningful Use Program Overview Who is eligible What is Meaningful Use (MU) How do you qualify How do you sign up How to determine

More information

Meaningful Use. Relevance. What is ARRA Meaningful Use? (American Recovery and Reinvestment Act of 2009)

Meaningful Use. Relevance. What is ARRA Meaningful Use? (American Recovery and Reinvestment Act of 2009) Meaningful Use First The What, Now The How S. Hughes Melton, MD President, C-Health, P.C. hmelton@c-healthonline.com Relevance Speedometer, Consumer Reports Your Teenager Provider A and B Google: Rate

More information

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Improving Quality of Care for Medicare Patients: FACT SHEET Overview http://www.cms.gov/sharedsavingsprogram On October

More information

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION OBJECTIVES Kimberly S. Hodge, PhDc, MSN, RN, ACNS-BC, CCRN- K Director, ACO Care Management & Clinical Nurse Specialist Franciscan ACO, Inc. Central Indiana Region Indianapolis, IN By the end of this session

More information

AAP GPCI QIP Using the EHR for quality improvement. Donald E. Lighter, MD, MBA, FAAP Director IHQRE Professor, The University of Tennessee, Knoxville

AAP GPCI QIP Using the EHR for quality improvement. Donald E. Lighter, MD, MBA, FAAP Director IHQRE Professor, The University of Tennessee, Knoxville AAP GPCI QIP Using the EHR for quality improvement Donald E. Lighter, MD, MBA, FAAP Director IHQRE Professor, The University of Tennessee, Knoxville Disclosures I have no relevant financial relationships

More information

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks Meaningful Use: Registration, Attestation, Workflow Tips and Tricks Allison L. Weathers, MD Medical Director, Information Services Rush University Medical Center Gregory J. Esper, MD, MBA Vice Chair, Neurology

More information

PQRS Clinical Quality Reporting

PQRS Clinical Quality Reporting PQRS clinical quality measure reporting is required to avoid Medicare payment rate reductions. This document summarizes the PQRS program and how it is aligned with Meaningful Use CQMs. PQRS Quality Reporting

More information

Cash for Clunkers. Meaningful Use: No Cash for Clunkers. EHR Certification & Meaningful Use

Cash for Clunkers. Meaningful Use: No Cash for Clunkers. EHR Certification & Meaningful Use Meaningful Use: No Cash for Clunkers EHR Certification & Meaningful Use ANCO/MOASC Business of Oncology: 2010 and Beyond October 28, 2010 Cash for Clunkers 2 1 NO Cash for Clunkers 3 What is a clunker?

More information

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly

More information

11/2/2015 Domain: Care Coordination / Patient Safety

11/2/2015 Domain: Care Coordination / Patient Safety 11/2/2015 Domain: Care Coordination / Patient Safety 2014 CT Commercial Medicaid Compared to 2012 all LOB Medicaid Quality Compass Benchmarks 2 3 4 5 6 7 8 9 10 Documentation of Current Medications in

More information

Foundations for Achieving Meaningful Use and Breaking Down EHR Barriers

Foundations for Achieving Meaningful Use and Breaking Down EHR Barriers Foundations for Achieving Meaningful Use and Breaking Down EHR Barriers Prepared by: Coker Group Physicians Institute 1849 The Exchange Atlanta, GA 30339 A BOUT THE PHYSICIANS INSTITUTE The Physicians'

More information

Medicare & Medicaid EHR Incentive Program Final Rule

Medicare & Medicaid EHR Incentive Program Final Rule Medicare & Medicaid EHR Incentive Program Final Rule Implementing the American Recovery and Reinvestment Act of 2009 Presented by: Kevin R. Burchill, Esq., FACHE Director Date: August 19, 2010 Overview

More information

Chapter Three Accountable Care Organizations

Chapter Three Accountable Care Organizations Chapter Three Accountable Care Organizations One of the most talked-about changes in health care delivery in recent decades is Accountable Care Organizations, or ACOs. Having gained the attention of both

More information

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents BMI Percentile (Total)

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents BMI Percentile (Total) Appendix C: New Performance Measures DOM Performance Measures Relevant HEDIS Measure(s) HEDIS 2012 Benchmark 50 th Percentile The 50 th percentile benchmarks are an indicator that half of the health plans

More information

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Improving Quality of Medicare Patients: Overview The Centers for Medicare & Medicaid Services (), an agency within the Department

More information

A Detailed Data Set From the Year 2011

A Detailed Data Set From the Year 2011 2012 HEDIS 2012 A Detailed Data Set From the Year 2011 Commercial Product We are pleased to present the AvMed HEDIS 2012 Report, a detailed data set designed to give employers and consumers an objective

More information

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmologists can register for the Medicare electronic health record (EHR) incentive program on the CMS website: https://ehrincentives.cms.gov

More information

ACO Program: Quality Reporting Requirements. Jennifer Faerberg Mary Wheatley April 28, 2011

ACO Program: Quality Reporting Requirements. Jennifer Faerberg Mary Wheatley April 28, 2011 ACO Program: Quality Reporting Requirements Jennifer Faerberg Mary Wheatley April 28, 2011 Agenda for Today s Call Overview Quality Reporting Requirements Benchmarks/Thresholds Scoring Model Scoring Methodology

More information

Meaningful Use Stage 2: Important Implications for Pediatrics

Meaningful Use Stage 2: Important Implications for Pediatrics Meaningful Use Stage 2: Important Implications for Pediatrics Glossary of Acronyms MU CQM EHR CEHRT EPs CAHs e-rx CPOE emar ONC CMS HHS Meaningful Use Clinical quality measure Electronic health record

More information

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year Release Notes/Summary of Changes (February 2015): Issued correction of 2014 benchmarks for ACO-9 and ACO-10 quality

More information

HEdis Code Quick Reference Guide Disease Management Services

HEdis Code Quick Reference Guide Disease Management Services HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)

More information

Electronic Medical Records Meaningful Use Guide TABLE OF CONTENTS. Master Files to Update...2. Prepare Superbill Encounter Forms...

Electronic Medical Records Meaningful Use Guide TABLE OF CONTENTS. Master Files to Update...2. Prepare Superbill Encounter Forms... AMS Electronic Medical Records Meaningful Use Guide TABLE OF CONTENTS Master Files to Update...2 Prepare Superbill Encounter Forms...3 Patient Presents to Check In...3 Clinical Staff is Ready for Next

More information

Tuesday, May 6, 2014 12:00 Noon EDT Dial In: 1-877-267-1577 Meeting ID: 997 828 367 No audio available through Webinar

Tuesday, May 6, 2014 12:00 Noon EDT Dial In: 1-877-267-1577 Meeting ID: 997 828 367 No audio available through Webinar Aligning PQRS with Meaningful Use CQMs in 2014 Tuesday, May 6, 2014 12:00 Noon EDT Dial In: 1-877-267-1577 Meeting ID: 997 828 367 No audio available through Webinar 2 Objectives Discuss benefits of aligning

More information

Clinical Quality Measures for 2014 And Meaningful Use Updates. Lindsey Wiley, MHA HIT Manager

Clinical Quality Measures for 2014 And Meaningful Use Updates. Lindsey Wiley, MHA HIT Manager Clinical Quality Measures for 2014 And Meaningful Use Updates Lindsey Wiley, MHA HIT Manager An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906-0123. Step 2: Enter code 2071585#.

More information

2010 QARR QUICK REFERENCE GUIDE Adults

2010 QARR QUICK REFERENCE GUIDE Adults 2010 QARR QUICK REFERENCE GUIDE Adults ADULT MEASURES (19 through 64 years) GUIDELINE HEDIS COMPLIANT CPT/ICD9 CODES DOCUMENTATION TIPS Well Care Access to Ambulatory Care Ensure a preventive or other

More information

"2015 ACO quality measures- What's new? How can we be successful?"

2015 ACO quality measures- What's new? How can we be successful? "2015 ACO quality measures- What's new? How can we be successful?" ACO Announcements Reminders: ACO Notifications, Requests for Tax ID information from PECOS, Upcoming Boardline Upcoming Specialty Initiative

More information

DRAFT. To Whom It May Concern:

DRAFT. To Whom It May Concern: DRAFT Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1345-P, P.O. Box 8013, Baltimore, MD 21244-8013 To Whom It May Concern: As a nonprofit, nonpartisan

More information

ACO Name and Location Allina Health Minneapolis, Minnesota

ACO Name and Location Allina Health Minneapolis, Minnesota ACO Name and Location Allina Health Minneapolis, Minnesota ACO Primary Contact Patrick Flesher Director, Payer Contracting & Pioneer ACO Program Email: Patrick.Flesher@allina.com Phone: 612-262-4865 Composition

More information

Test Procedure for 170.302 (l) Public Health Surveillance

Test Procedure for 170.302 (l) Public Health Surveillance Test Procedure for 170.302 (l) Public Health Surveillance This document describes the test procedure for evaluating conformance of complete EHRs or EHR modules 1 to the certification criteria defined in

More information

Measure Steward. E-Measure ID National Quality Strategy Domain Measure Title and Description. Other Quality Reporting

Measure Steward. E-Measure ID National Quality Strategy Domain Measure Title and Description. Other Quality Reporting 343 TABLE 25: Existing Individual and Those Included in for the for Which Measure Updates will be Beginning in 2015 006 7/6 Coronary Artery Disease (CAD): Antiplatelet Therapy: Percentage of patients aged

More information

Healthcare Effectiveness Data and Information Set (HEDIS ) Guide

Healthcare Effectiveness Data and Information Set (HEDIS ) Guide Healthcare Effectiveness Data and Information Set (HEDIS ) Guide Clinical ALL ADULTS Access to preventive/ ambulatory health services Smoking and Tobacco Use Cessation [S] Aspirin Use and Discussion [S]

More information

Allscripts CQS Planning for 2014 Webinar: FAQs

Allscripts CQS Planning for 2014 Webinar: FAQs Allscripts CQS Planning for 2014 Webinar: FAQs Listed below are questions asked by attendees based on the CQS Planning for 2014 Webinars, held on May 8, May 28, and May 30, 2014. Answers are provided below.

More information

AMERICAN COLLEGE OF PHYSICIANS GENESIS REGISTRY IN COLLOBRATION WITH CECITY. 2015 PQRS & Non-PQRS Narrative Measure Specifications

AMERICAN COLLEGE OF PHYSICIANS GENESIS REGISTRY IN COLLOBRATION WITH CECITY. 2015 PQRS & Non-PQRS Narrative Measure Specifications AMERICAN COLLEGE OF PHYSICIANS GENESIS REGISTRY IN COLLOBRATION WITH CECITY 2015 PQRS & Non-PQRS Narrative Measure Specifications 1 Table of Contents Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor

More information

Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals. Objectives. National Organizations: Key Linkages

Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals. Objectives. National Organizations: Key Linkages Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals Kasey K. Thompson, Pharm.D. Director, Practice Standards and Quality Division Director, Patient Safety American

More information

Medicare Shared Savings Program Quality Measure Benchmarks for the 2015 Reporting Year

Medicare Shared Savings Program Quality Measure Benchmarks for the 2015 Reporting Year Medicare Shared Savings Program Quality Measure Benchmarks for the 2015 Reporting Year Release Notes/Summary of Changes (February 2015): Issued correction of 2015 benchmarks for ACO-9 and ACO-10 quality

More information

PROGRAM ASSISTANCE LETTER

PROGRAM ASSISTANCE LETTER PROGRAM ASSISTANCE LETTER DOCUMENT NUMBER: 2014-01 DATE: December 13, 2013 DOCUMENT TITLE: Approved Uniform Data System Changes for Calendar Year 2014 TO: Health Centers Primary Care Associations Primary

More information

SUMMARY TABLE OF MEASURE CHANGES

SUMMARY TABLE OF MEASURE CHANGES Summary Table of Measure 1 SUMMARY TABLE OF MEASURE CHANGES Guidelines for Physician Measurement Effectiveness of Preventive Care Guidelines for Physician Effectiveness of Care Adult BMI Assessment Weight

More information

Meaningful Use: Making use of Clinical Decision Support. Matt Allison

Meaningful Use: Making use of Clinical Decision Support. Matt Allison Meaningful Use: Making use of Clinical Decision Support Matt Allison Preparing for Meaningful Use ARRA/HITECH Goals Overview Final Rule for MU Stage 1 Medicare Program Utilizing Clinical Decision Support

More information

2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes

2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes 2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes This document contains a description of HEDIS and other quality of care measures and includes suggestions and/or recommendations

More information

Explanation of CMS Proposed Performance Measurement Framework for ACOs and Comparison with IHA P4P Measure Set April 2011

Explanation of CMS Proposed Performance Measurement Framework for ACOs and Comparison with IHA P4P Measure Set April 2011 Explanation of CMS Proposed Performance ment Framework for ACOs and Comparison with IHA P4P Set April 2011 This briefing outlines Section II E ( and Other Reporting Requirements) of the Shared Savings

More information

InteGreat EHR Meaningful Use 2 Features and Reports Jenni Walters, Sr. Business Analyst, McKesson Beth Crews, Business Analyst, McKesson

InteGreat EHR Meaningful Use 2 Features and Reports Jenni Walters, Sr. Business Analyst, McKesson Beth Crews, Business Analyst, McKesson InteGreat EHR Meaningful Use 2 Features and Reports Jenni Walters, Sr. Business Analyst, McKesson Beth Crews, Business Analyst, McKesson Stage 2 Overview On September 4, 2012, CMS published final rule

More information

2014 Medicare Physician Fee Schedule Proposed Rule Quality Provisions

2014 Medicare Physician Fee Schedule Proposed Rule Quality Provisions 2014 Medicare Physician Fee Schedule Proposed Rule Quality Provisions The 2014 Medicare Physician Fee Schedule (MPFS) Notice of Proposed Rulemaking (NPRM) was published in the Federal Register on July

More information

Manitoba EMR Data Extract Specifications

Manitoba EMR Data Extract Specifications MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the

More information

2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide

2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide 2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide HEDIS Measure: Test/Care Needed for Compliance Adult BMI Assessment Individuals ages 18-74 Documentation of BMI and

More information

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures Ohio Health Homes Learning Community Meeting Overview of Health Homes Measures Tuesday, March 5, 2013 Presenter: Amber Saldivar, MHSM Associate Director, Informatics Analysis Health Services Advisory Group,

More information

Primary Care Quality Care Indicators - Accuro EMR Prevention

Primary Care Quality Care Indicators - Accuro EMR Prevention Quality Indicators Primary Care Quality Care Indicators - Accuro EMR Prevention Data needs to be entered as indicated in order to auto populate the worksheet Date of colon cancer screening Exemption from

More information

January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose Important Changes for 2014 PQRS PQRS Incentive Individual EPs

January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose Important Changes for 2014 PQRS PQRS Incentive Individual EPs January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose This fact sheet includes important information about changes to the Physician Quality Reporting System (PQRS) for 2014.

More information

SUMMARY TABLE OF MEASURE CHANGES

SUMMARY TABLE OF MEASURE CHANGES SUMMARY TABLE OF MEASURE CHANGES Measure Name Effectiveness of Preventive Care Adult BMI Assessment Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents Childhood

More information

Vermont ACO Shared Savings Program Quality Measures: Recommendations for Year 2 Measures from the VHCIP Quality and Performance Measures Work Group

Vermont ACO Shared Savings Program Quality Measures: Recommendations for Year 2 Measures from the VHCIP Quality and Performance Measures Work Group Vermont ACO Shared Savings Program Quality Measures: Recommendations for Year 2 Measures from the VHCIP Quality and Performance Measures Work Group Presentation to VHCIP Steering Committee August 6, 2014

More information

Meaningful Use Quality Measures

Meaningful Use Quality Measures Allscripts Enterprise Meaningful Use Quality Measures Report ambulatory clinical quality measures to CMS (or for EPs seeking the Medicaid incentive payment, to the states) Copyright 2010 Allscripts Healthcare

More information

HEDIS Code Quick Reference Guide Preventive/Ambulatory Services

HEDIS Code Quick Reference Guide Preventive/Ambulatory Services HEDIS Code Quick Reference Guide Preventive/Ambulatory Services Child/Adolescent Care Well-Child Visits in the First 15 Months of Life [Commercial, Medicaid] Well-Child Visits in the Third, Fourth, Fifth

More information

Achieving Quality and Value in Chronic Care Management

Achieving Quality and Value in Chronic Care Management The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of

More information

Welcome The AAMC, UHC and FPSC Web Conference on 2014 PQRS Proposed Changes will begin shortly.

Welcome The AAMC, UHC and FPSC Web Conference on 2014 PQRS Proposed Changes will begin shortly. Welcome The AAMC, UHC and FPSC Web Conference on 2014 PQRS Proposed Changes will begin shortly. Please do not place your phones on hold. If you need to leave the event, hang up and dial back into the conference.

More information

New Jersey Delivery System Reform Incentive Program

New Jersey Delivery System Reform Incentive Program New Jersey Delivery System Reform Incentive Program The New Jersey Delivery System Reform Incentive Program (DSRIP) is part of New Jersey s Comprehensive Medicaid Waiver. The program provides incentive

More information

The Role of Health Information Technology in Improving Health Care

The Role of Health Information Technology in Improving Health Care The Role of Health Information Technology in Improving Health Care The HIT Symposium Massachusetts Institute of Technology July 1, 2009 Michael T. Rapp, MD, JD, FACEP Director, Quality Measurement and

More information

CMS s Proposed Clinical Quality Measures for Eligible Professionals

CMS s Proposed Clinical Quality Measures for Eligible Professionals CMS s Proposed Quality s for Eligible Professionals The following table is available in CMS s proposed rule, available at http://www.gpo.gov/fdsys/pkg/fr-2012-03-07/pdf/2012-4443.pdf. CMS proposes to require

More information

PROGRAM ASSISTANCE LETTER

PROGRAM ASSISTANCE LETTER PROGRAM ASSISTANCE LETTER DOCUMENT NUMBER: PAL 2012-03 DATE: April 11, 2012 DOCUMENT TITLE: Approved Uniform Data System Changes for 2012 TO: Health Center Program Grantees Primary Care Associations Primary

More information

A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS

A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS The matrix below provides a comparison of all measures included in Medi-Cal P4P programs and the measures includes in DHCS s External Accountability

More information

WHAT ARE CLINICAL QUALITY MEASURES? IMPORTANT TERMS

WHAT ARE CLINICAL QUALITY MEASURES? IMPORTANT TERMS Practice Fusion 2014 Clinical Quality Measure Guide This guide will provide in depth information on the clinical quality measures that are available in Practice Fusion. WHAT ARE CLINICAL QUALITY MEASURES?

More information

EHRs and Meaningful Use: Benefits and Challenges for EPs

EHRs and Meaningful Use: Benefits and Challenges for EPs EHRs and Meaningful Use: Benefits and Challenges for EPs Presented by: Donna Garwood, RN, BSN, CPHQ KFMC HITREC Educator April 8, 2011 KAOM Overland Park, KS Acronyms REC ONC HITRC MU RHIO HIE ARRA HITECH

More information

Dashboard Overview Webinar

Dashboard Overview Webinar Regional Information for Shared Excellence (RISE) Initiative Dashboard Overview Webinar Jerry Lassa, MS Statistics May 15 & May 17, 2012 Do You Ever Spend a lot of time reviewing data trying to make sense

More information

Prevents future health problems. You receive these services without having any specific symptoms.

Prevents future health problems. You receive these services without having any specific symptoms. Preventive Care To help you live the healthiest life possible, we offer free preventive services for most Network Health members. Please refer to your member materials, which you received when you enrolled

More information

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE V 9.0 eclinicalworks, 2013. All rights reserved Contents CONTENTS ACO SETUP 3 Demographics 3 ACO 12 4 ACO 13 6 ACO 14 7 ACO 15 8 ACO 16 9 ACO 17

More information

Total Health Quality Indicators For Providers 2015

Total Health Quality Indicators For Providers 2015 Total Health Quality Indicators For Providers 2015 Adult- Preventive Measure Test/Procedure Parameters Frequency CPT/HCPCS CPT II ICD-9 BMI Assessment BMI Recording 18-74 yrs Yearly G8417, G8418, G8420

More information

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++ Hospitalizations Inpatient Utilization General Hospital/Acute Care (IPU) * This measure summarizes utilization of acute inpatient care and services in the following categories: Total inpatient. Medicine.

More information

Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT

Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT December 2014 This report was produced by Health Services Advisory Group, Inc. for the Colorado Department of Health Care Policy and Financing.

More information

Health Information Technology in the Real World. By C. Kerry Stratford, MD

Health Information Technology in the Real World. By C. Kerry Stratford, MD Health Information Technology in the Real World By C. Kerry Stratford, MD Goals for a satisfying practice Do what we are trained to do without distracting hassles Have some independence and freedom in

More information